LncRNA-MALAT1 promotes triple-negative breast cancer progression and function as ceRNA to target REEP5 by sponging miR-106a-5p

被引:0
作者
Yang, Qiu-hui [1 ]
Fu, Ye-qin [2 ]
Feng, Wei-liang [2 ]
Mao, Jie-fei [2 ]
Xu, Ning [2 ]
Liu, Qing [1 ]
Yan, Qian-jun [1 ]
Yang, Hong-jian [2 ]
Zhang, Xi-ping [2 ]
机构
[1] Zhejiang Chinese Med Univ, Zhejiang Prov Hosp Tradit Chinese Med, Affiliated Hosp 1, Hangzhou 310006, Zhejiang, Peoples R China
[2] Chinese Acad Sci, Zhejiang Canc Hosp, HIM, Dept Breast Surg, Hangzhou 310022, Zhejiang, Peoples R China
关键词
Triple negative breast cancer (TNBC); Long non-coding RNA (lncRNA); Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1); Competing endogenous RNA (ceRNA); Biomarkers; Prognosis; AXIS; PROLIFERATION; MICRORNA; LNCRNA; ROLES;
D O I
10.1186/s40001-025-02420-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Axillary lymph node metastasis (ALNM) in triple negative breast cancer (TNBC) will lead to poor prognosis. Recent studies have shown that long non-coding RNAs (lncRNAs) were involved in the progression of tumors. This study aimed to explore the role and mechanism of lncRNA-MALAT1 in the progression of TNBC and its relationship with ALNM. MALAT1 is highly expressed in TNBC cells lines, tumor tissues and serum, and it is positively correlated with the degree of ALNM. In addition, MALAT1 can act as a competitive endogenous RNA (ceRNA) that regulates cellular biological behavior by competitively binding to miR-106a-5p with REEP5. In conclusion, our results show that MALAT1 could function as ceRNA promote the proliferation, invasion and metastasis of TNBC cells through MALAT1/miR-106a-5p/REEP5 axis, which is expected to provide new ideas for the diagnosis of TNBC in clinic.
引用
收藏
页数:18
相关论文
共 45 条
  • [21] Mechanisms of circRNA/lncRNA-miRNA interactions and applications in disease and drug research
    Ma, Benchi
    Wang, Shihao
    Wu, Wenzheng
    Shan, Pufan
    Chen, Yufan
    Meng, Jiaqi
    Xing, Liping
    Yun, Jingyi
    Hao, Longhui
    Wang, Xiaoyu
    Li, Shuyan
    Guo, Yinghui
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [22] Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases
    Mao, Hui
    Chen, Wei
    Chen, Linxi
    Li, Lanfang
    [J]. BIOCHEMICAL PHARMACOLOGY, 2022, 199
  • [23] The accessory proteins REEP5 and REEP6 refine CXCR1-mediated cellular responses and lung cancer progression
    Park, Cho Rong
    You, Dong-Joo
    Park, Sumi
    Mander, Sunam
    Jang, Da-Eun
    Yeom, Su-Cheong
    Oh, Seong-Hyun
    Ahn, Curie
    Lee, Sang Heon
    Seong, Jae Young
    Hwang, Jong-Ik
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [24] Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
    Rossing, Maria
    Pedersen, Christina Bligaard
    Tvedskov, Tove
    Vejborg, Ilse
    Talman, Maj-Lis
    Olsen, Lars Ronn
    Kroman, Niels
    Nielsen, Finn Cilius
    Jensen, Maj-Britt
    Ejlertsen, Bent
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer
    Silva, Camila Meirelles S.
    Barros-Filho, Mateus C.
    Wong, Deysi Viviana T.
    Mello, Julia Bette H.
    Nobre, Livia Maria S.
    Wanderley, Carlos Wagner S.
    Lucetti, Larisse T.
    Muniz, Heitor A.
    Paiva, Igor Kenned D.
    Kuasne, Hellen
    Ferreira, Daniel Paula P.
    Cunha, Maria Perpetuo S. S.
    Hirth, Carlos G.
    Silva, Paulo Goberlanio B.
    Sant'Ana, Rosane O.
    Souza, Marcellus Henrique L. P.
    Quetz, Josiane S.
    Rogatto, Silvia R.
    Lima-Junior, Roberto Cesar P.
    [J]. CANCERS, 2021, 13 (07)
  • [26] Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
    Singh, Jagdeep K.
    Farnie, Gillian
    Bundred, Nigel J.
    Simoes, Bruno M.
    Shergill, Amrita
    Landberg, Goeran
    Howell, Sacha J.
    Clarke, Robert B.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (03) : 643 - 656
  • [27] A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer
    Sun, Jie
    Li, Xiaohua
    Yu, Enqiao
    Liu, Jianxia
    Sun, Liang
    He, Qin
    Lu, Qiran
    [J]. DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [28] Endogenous microRNA sponges: evidence and controversy
    Thomson, Daniel W.
    Dinger, Marcel E.
    [J]. NATURE REVIEWS GENETICS, 2016, 17 (05) : 272 - 283
  • [29] The Landscape of Targeted Therapies in TNBC
    Vagia, Elena
    Mahalingam, Devalingam
    Cristofanilli, Massimo
    [J]. CANCERS, 2020, 12 (04)
  • [30] EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
    Verma, Ayushi
    Singh, Akhilesh
    Singh, Manish Pratap
    Nengroo, Mushtaq Ahmad
    Saini, Krishan Kumar
    Satrusal, Saumya Ranjan
    Khan, Muqtada Ali
    Chaturvedi, Priyank
    Sinha, Abhipsa
    Meena, Sanjeev
    Singh, Anup Kumar
    Datta, Dipak
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)